-
1
-
-
1842863012
-
Molecular and cellular effects of c-peptidednew perspectives on an old peptide
-
Wahren J, Shafqat J, Johansson J, Chibalin A, Ekberg K, Jörnvall H. Molecular and cellular effects of C-peptidednew perspectives on an old peptide. Exp Diabesity Res 2004;5:15-"23
-
(2004)
Exp Diabesity Res
, vol.5
, pp. 15-23
-
-
Wahren, J.1
Shafqat, J.2
Johansson, J.3
Chibalin, A.4
Ekberg, K.5
Jörnvall, H.6
-
3
-
-
33846075220
-
C-peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
-
Ekberg K, Brismar T, Johansson BL, et al. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy. Diabetes Care 2007;30:71-"76
-
(2007)
Diabetes Care
, vol.30
, pp. 71-76
-
-
Ekberg, K.1
Brismar, T.2
Johansson, B.L.3
-
4
-
-
0026488266
-
Effects of c-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulindependent) diabetic patients
-
Johansson BL, Linde B, Wahren J. Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulindependent) diabetic patients. Diabetologia 1992;35:1151-"1158
-
(1992)
Diabetologia
, vol.35
, pp. 1151-1158
-
-
Johansson, B.L.1
Linde, B.2
Wahren, J.3
-
5
-
-
0026558822
-
The influence of human c-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients
-
Johansson BL, Sjöberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 1992;35:121-"128
-
(1992)
Diabetologia
, vol.35
, pp. 121-128
-
-
Johansson, B.L.1
Sjöberg, S.2
Wahren, J.3
-
6
-
-
12144288815
-
Cpeptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro
-
Marx N, Walcher D, Raichle C, et al. Cpeptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler Thromb Vasc Biol 2004;24:540- "545
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 540-545
-
-
Marx, N.1
Walcher, D.2
Raichle, C.3
-
7
-
-
3042786038
-
Cpeptide induces chemotaxis of human cd4-positive cells: Involvement of pertussis toxin-sensitive g-proteins and phosphoinositide 3-kinase
-
Walcher D, Aleksic M, Jerg V, et al. Cpeptide induces chemotaxis of human CD4-positive cells: involvement of pertussis toxin-sensitive G-proteins and phosphoinositide 3-kinase. Diabetes 2004; 53:1664-"1670
-
(2004)
Diabetes
, vol.53
, pp. 1664-1670
-
-
Walcher, D.1
Aleksic, M.2
Jerg, V.3
-
8
-
-
84867851421
-
Cpeptide promotes lesion development in a mouse model of arteriosclerosis
-
Vasic D, Marx N, Sukhova G, et al. Cpeptide promotes lesion development in a mouse model of arteriosclerosis. J Cell Mol Med 2012;16:927-"935
-
(2012)
J Cell Mol Med
, vol.16
, pp. 927-935
-
-
Vasic, D.1
Marx, N.2
Sukhova, G.3
-
9
-
-
80054110857
-
C-peptide reduces high-glucose-induced apoptosis of endothelial cells and decreases nad(p)h-oxidase reactive oxygen species generation in human aortic endothelial cells
-
Cifarelli V, Geng X, Styche A, Lakomy R, Trucco M, Luppi P. C-peptide reduces high-glucose-induced apoptosis of endothelial cells and decreases NAD(P)H-oxidase reactive oxygen species generation in human aortic endothelial cells. Diabetologia 2011;54:2702-"2712
-
(2011)
Diabetologia
, vol.54
, pp. 2702-2712
-
-
Cifarelli, V.1
Geng, X.2
Styche, A.3
Lakomy, R.4
Trucco, M.5
Luppi, P.6
-
10
-
-
48149103214
-
Human c-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappab pathway
-
Luppi P, Cifarelli V, Tse H, Piganelli J, Trucco M. Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway. Diabetologia 2008;51:1534-"1543
-
(2008)
Diabetologia
, vol.51
, pp. 1534-1543
-
-
Luppi, P.1
Cifarelli, V.2
Tse, H.3
Piganelli, J.4
Trucco, M.5
-
11
-
-
77955518344
-
Cellular mechanisms by which proinsulin c-peptide prevents insulin-induced neointima formation in human saphenous vein
-
Mughal RS, Scragg JL, Lister P, et al. Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein. Diabetologia 2010;53:1761-"1771
-
(2010)
Diabetologia
, vol.53
, pp. 1761-1771
-
-
Mughal, R.S.1
Scragg, J.L.2
Lister, P.3
-
12
-
-
79951968328
-
Fasting c-peptide levels and death resulting from all causes and breast cancer: The health, eating, activity, and lifestyle study
-
Irwin ML, Duggan C, Wang CY, et al. Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study. J Clin Oncol 2011;29:47-"53
-
(2011)
J Clin Oncol
, vol.29
, pp. 47-53
-
-
Irwin, M.L.1
Duggan, C.2
Wang, C.Y.3
-
13
-
-
54349083481
-
Prediagnostic body-mass index, plasma c-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: A long-term survival analysis
-
Ma J, Li H, Giovannucci E, et al. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol 2008;9:1039-"1047
-
(2008)
Lancet Oncol
, vol.9
, pp. 1039-1047
-
-
Ma, J.1
Li, H.2
Giovannucci, E.3
-
14
-
-
0034937299
-
Rationale and design of the luric studyda resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease
-
LURIC Study Group (LUdwigshafen RIsk and Cardiovascular Health)
-
Winkelmann BR, März W, Boehm BO, et al.; LURIC Study Group (LUdwigshafen RIsk and Cardiovascular Health). Rationale and design of the LURIC studyda resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2001;2(Suppl. 1):S1-"S73
-
(2001)
Pharmacogenomics
, vol.2
, Issue.SUPPL. 1
-
-
Winkelmann, B.R.1
März, W.2
Boehm, B.O.3
-
15
-
-
75149130955
-
Diagnosis and classification of diabetes mellitus
-
American Diabetes Association
-
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl. 1):S62-S69
-
(2010)
Diabetes Care
, vol.33
, Issue.SUPPL. 1
-
-
-
18
-
-
80052003268
-
Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography
-
Silbernagel G, Grammer TB, Winkelmann BR, Boehm BO, März W. Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography. Diabetes Care 2011;34:1355-"1361
-
(2011)
Diabetes Care
, vol.34
, pp. 1355-1361
-
-
Silbernagel, G.1
Grammer, T.B.2
Winkelmann, B.R.3
Boehm, B.O.4
März, W.5
-
19
-
-
44449099304
-
Relationship of glycemic control, exogenous insulin, and c-peptide levels to ischemic heart disease mortality over a 16-year period in people with olderonset diabetes: The wisconsin epidemiologic study of diabetic retinopathy (wesdr)
-
Hirai FE, Moss SE, Klein BE, Klein R. Relationship of glycemic control, exogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in people with olderonset diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR). Diabetes Care 2008;31:493-497
-
(2008)
Diabetes Care
, vol.31
, pp. 493-497
-
-
Hirai, F.E.1
Moss, S.E.2
Klein, B.E.3
Klein, R.4
-
20
-
-
33751319145
-
Cpeptide induces vascular smooth muscle cell proliferation: Involvement of srckinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2
-
Walcher D, Babiak C, Poletek P, et al. CPeptide induces vascular smooth muscle cell proliferation: involvement of SRCkinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2. Circ Res 2006;99:1181-"1187
-
(2006)
Circ Res
, vol.99
, pp. 1181-1187
-
-
Walcher, D.1
Babiak, C.2
Poletek, P.3
|